plRL58 Citations (3)

Originally described in: Genome-wide gene expression tuning reveals diverse vulnerabilities of M. tuberculosis.
Bosch B, DeJesus MA, Poulton NC, Zhang W, Engelhart CA, Zaveri A, Lavalette S, Ruecker N, Trujillo C, Wallach JB, Li S, Ehrt S, Chait BT, Schnappinger D, Rock JM Cell. 2021 Jul 16. pii: S0092-8674(21)00824-2. doi: 10.1016/j.cell.2021.06.033. PubMed Journal

---

Articles Citing plRL58

Articles
The essential M. tuberculosis Clp protease is functionally asymmetric in vivo. d'Andrea FB, Poulton NC, Froom R, Tam K, Campbell EA, Rock JM. Sci Adv. 2022 May 6;8(18):eabn7943. doi: 10.1126/sciadv.abn7943. Epub 2022 May 4. PubMed
CRISPRi chemical genetics and comparative genomics identify genes mediating drug potency in Mycobacterium tuberculosis. Li S, Poulton NC, Chang JS, Azadian ZA, DeJesus MA, Ruecker N, Zimmerman MD, Eckartt KA, Bosch B, Engelhart CA, Sullivan DF, Gengenbacher M, Dartois VA, Schnappinger D, Rock JM. Nat Microbiol. 2022 Jun;7(6):766-779. doi: 10.1038/s41564-022-01130-y. Epub 2022 May 30. PubMed
Cyclic AMP is a critical mediator of intrinsic drug resistance and fatty acid metabolism in M. tuberculosis. Wong AI, Beites T, Planck KA, Fieweger RA, Eckartt KA, Li S, Poulton NC, VanderVen BC, Rhee KY, Schnappinger D, Ehrt S, Rock J. Elife. 2023 Feb 22;12:e81177. doi: 10.7554/eLife.81177. PubMed

If you have published an article using this material, please email us at to have your article added to this page.